Narrow search
Showing 81 - 90 of 196,509
Cover Image
IPRs and technological development in pharmaceuticals : who is patenting what in Brazil after TRIPS?
Laforgia, Francesco; Montobbio, Fabio; Orsenigo, Luigi - In: The development agenda : global intellectual property …, (pp. 293-317). 2009
Persistent link: https://www.econbiz.de/10003910937
Cover Image
Intellectual property rights and pharmaceutical development
Rovira Forns, Joan - In: The economics of new health technologies : incentives, …, (pp. 219-239). 2009
Persistent link: https://www.econbiz.de/10003916101
Cover Image
A cross-country index of intellectual property rights in pharmaceutical inventions
Liu, Ming; La Croix, Sumner J. - In: Research policy : policy, management and economic … 44 (2015) 1, pp. 206-216
Persistent link: https://www.econbiz.de/10011317950
Cover Image
Biopharmaceuticals under the patient protection and affordable care act : determining the appropriate market and data exclusive periods
Gitter, Donna M. - In: The changing face of US patent law and its impact on …, (pp. 211-229). 2013
Persistent link: https://www.econbiz.de/10009788426
Cover Image
The new political economy of pharmaceuticals : production, innnovation and TRIPS in the global south
Löfgren, Hans (contributor) - 2013
agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its … rules on pharmaceutical patents. This volume is the first cross-country analysis of how TRIPS has affected the capacity of …
Persistent link: https://www.econbiz.de/10009793209
Cover Image
Patentability of Pharmaceutical Inventions Under TRIPS : Domestic Court Practice as a Test for International Policy Space
Grosse Ruse-Khan, Henning - 2017
This article examines the leeway the TRIPS Agreement grants to WTO Members to define their own standard of … abstractly analyzing the boundaries set by Article 27 TRIPS, it takes up specific questions related to patentability raised … before national judges where the TRIPS consistency of a domestic practice or interpretation has been an issue. In this …
Persistent link: https://www.econbiz.de/10012969977
Cover Image
United States Special 301 : a deeply flawed tool for IPR regulation?
Qureshi, Asif H. - In: Journal of world trade : law, economic policy, public policy 55 (2021) 3, pp. 499-520
Persistent link: https://www.econbiz.de/10012609439
Cover Image
The Universal Destination of Pharmaceutical Patents : Reflecting on TRIPS Through the Lens of Aquinas
Castree, Sam - 2015
Debates continue to rage about the propriety of pharmaceutical patents, especially as required by the TRIPS Agreement … whether TRIPS is indeed a just law. One can also realize the steps that the major players – both nations and pharmaceutical …
Persistent link: https://www.econbiz.de/10013034855
Cover Image
TRIPS Flexibilities on Patent Enforcement : Lessons from Some Developed Countries Relating to Pharmaceutical Patent Protection
Sarnoff, Joshua D. - 2021
-Related Aspects of Intellectual Property Rights (TRIPS), Articles 44 and 50. But the TRIPS Agreement does not require the issuance of … preliminary injunctions. Consistent with the TRIPS Agreement, developing country judges may make different choices, based on the …
Persistent link: https://www.econbiz.de/10013212673
Cover Image
One Product, Many Patents : Imperfect Intellectual Property Rights in the Pharmaceutical Industry
Gupta, Charu - 2021
Economists’ standard notion of intellectual property rights considers a single patent per product, with a clearly defined scope, certain enforcement, and a fixed term of monopoly protection. Yet common across industries are “imperfect” intellectual property rights: More than one patent may...
Persistent link: https://www.econbiz.de/10013247110